Vishal Shete
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Vishal Shete has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Meena Mishra
5 shared publicationsNeeta Gade
4 shared publicationsNivedita Gupta
Division of Epidemiology & Communicate Diseases, Indian Council of Medical Research, New Delhi, India
4 shared publicationsVasna Joshua
ICMR - National Institute of Epidemiology, Chennai, Tamil Nadu, India
3 shared publicationsB K Kirubakaran
Indian Council of Medical Research–National Institute of Epidemiology, R127, Tamil Nadu Housing Board, Ayapakkam, Chennai, Tamil Nadu, India
2 shared publicationsK Kanagasabai
Indian Council of Medical Research–National Institute of Epidemiology, R127, Tamil Nadu Housing Board, Ayapakkam, Chennai, Tamil Nadu, India
2 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 323
Whole-genome sequencing of SARS-CoV-2 virus in clinical isolates at a tertiary care centre: A retrospective cross-sectional study
- 22 September 2026
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 323
Open AccessWhole-genome sequencing of SARS-CoV-2 virus in clinical isolates at a tertiary care centre: A retrospective cross-sectional study
- Open Access
- 18 May 2026
- Published by Frontiers Media SA in Frontiers in Tropical Diseases
- Vol. 7, 1822411
Circulating dengue virus serotypes in central India: a molecular surveillance study
Introduction: India ranks among the top 30 countries with the highest incidence of dengue disease. The first indigenous vaccine to combat all four dengue serotypes is planned to have a market entry by 2027. Thus, determining the infecting serotype through molecular assays becomes essential. The objectives of the study are to determine the circulating serotype in dengue-positive cases and to examine the relationship between serotype and disease severity. Methodology: Suspected dengue samples with less than or equal to 5 days post-disease onset (acute-phase samples) were subjected to dengue nonstructural protein 1 (NS1) enzyme-linked immunosorbent assay (ELISA), and positive serum samples were further serotyped. For samples with more than 5 days post-onset (late-phase samples), DENV immunoglobulin M (IgM) ELISA was performed, and further dengue IgM-positive sera samples were processed for RT-PCR to detect DENV RNA. DENV RNA-positive samples were serotyped. Results: All 30 dengue serotype-positive patients presented with fever (100%), with headache as the second most common symptom ( n = 12, 40%). Thrombocytopenia was observed in eight (26.7%) patients, of whom three required platelet transfusion. No cases showed hemorrhagic manifestations or features of plasma leakage. The median duration of hospital stay was 7 days [interquartile range (IQR): 5.25–10 days], and clinical recovery was documented in 25 (83.3%) patients. Serotype analysis demonstrated circulation of dengue virus serotype-1 (DENV-1), DENV-2, and DENV-3, with DENV-2 being the predominant serotype (50%). Notably, eight (27%) cases showed hybrid serotype infections, indicating concurrent circulation of multiple dengue virus serotypes. Conclusion: This study emphasizes the hyperendemic nature of dengue in India, with DENV-2 as the predominant circulating serotype, whereas DENV-4 was not identified and appears to be less frequently reported in the region. The dynamic replacement of dominant serotypes over time depends on multiple factors and warrants further study; mixed serotype infections in a substantial proportion of cases indicate simultaneous circulation of multiple serotypes.
- 18 May 2026
- Published by Frontiers Media SA in Frontiers in Tropical Diseases
- Vol. 7, 1822411
Open AccessCirculating dengue virus serotypes in central India: a molecular surveillance study
Introduction: India ranks among the top 30 countries with the highest incidence of dengue disease. The first indigenous vaccine to combat all four dengue serotypes is planned to have a market entry by 2027. Thus, determining the infecting serotype through molecular assays becomes essential. The objectives of the study are to determine the circulating serotype in dengue-positive cases and to examine the relationship between serotype and disease severity. Methodology: Suspected dengue samples with less than or equal to 5 days post-disease onset (acute-phase samples) were subjected to dengue nonstructural protein 1 (NS1) enzyme-linked immunosorbent assay (ELISA), and positive serum samples were further serotyped. For samples with more than 5 days post-onset (late-phase samples), DENV immunoglobulin M (IgM) ELISA was performed, and further dengue IgM-positive sera samples were processed for RT-PCR to detect DENV RNA. DENV RNA-positive samples were serotyped. Results: All 30 dengue serotype-positive patients presented with fever (100%), with headache as the second most common symptom ( n = 12, 40%). Thrombocytopenia was observed in eight (26.7%) patients, of whom three required platelet transfusion. No cases showed hemorrhagic manifestations or features of plasma leakage. The median duration of hospital stay was 7 days [interquartile range (IQR): 5.25–10 days], and clinical recovery was documented in 25 (83.3%) patients. Serotype analysis demonstrated circulation of dengue virus serotype-1 (DENV-1), DENV-2, and DENV-3, with DENV-2 being the predominant serotype (50%). Notably, eight (27%) cases showed hybrid serotype infections, indicating concurrent circulation of multiple dengue virus serotypes. Conclusion: This study emphasizes the hyperendemic nature of dengue in India, with DENV-2 as the predominant circulating serotype, whereas DENV-4 was not identified and appears to be less frequently reported in the region. The dynamic replacement of dominant serotypes over time depends on multiple factors and warrants further study; mixed serotype infections in a substantial proportion of cases indicate simultaneous circulation of multiple serotypes.
- Open Access
- 1 December 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (4) , 2415-2428
Phage Therapy for Pseudomonas aeruginosa Lung Infections: A Review
Pseudomonas aeruginosa is a leading cause of persistent and severe lung infections, especially in individuals with weakened immune systems and those suffering from conditions like cystic fibrosis or bronchiectasis. The pathogen’s resistance to antibiotics, driven by its ability to form biofilms, activate efflux pumps, and produce enzymes that break down drugs, has significantly limited the effectiveness of standard antimicrobial therapies. This review explores the increasing promise of bacteriophage therapy as both an alternative and a complementary approach for addressing multidrug-resistant (MDR) P. aeruginosa infections in the lungs. Phages, viruses that specifically target bacteria, offer strain-specific bactericidal activity, often bypassing mechanisms of antibiotic resistance. Recent studies demonstrate that phage monotherapy and phage-antibiotic combinations can effectively disrupt biofilms and enhance bacterial clearance, particularly when phage cocktails or targeted delivery systems are employed. Additionally, the review explores delivery routes for pulmonary infections and the formulation challenges that affect phage stability and bioavailability. Clinical cases and ongoing trials further underscore the feasibility and safety of phage therapy in real-world applications. However, hurdles such as phage immunogenicity, rapid clearance, and regulatory limitations must be addressed before widespread clinical implementation. Overall, phage therapy holds significant promise in overcoming the therapeutic stagnation posed by MDR P. aeruginosa, especially in chronic and nosocomial lung infections, and warrants continued research and clinical validation.
- 1 December 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (4) , 2415-2428
Open AccessPhage Therapy for Pseudomonas aeruginosa Lung Infections: A Review
Pseudomonas aeruginosa is a leading cause of persistent and severe lung infections, especially in individuals with weakened immune systems and those suffering from conditions like cystic fibrosis or bronchiectasis. The pathogen’s resistance to antibiotics, driven by its ability to form biofilms, activate efflux pumps, and produce enzymes that break down drugs, has significantly limited the effectiveness of standard antimicrobial therapies. This review explores the increasing promise of bacteriophage therapy as both an alternative and a complementary approach for addressing multidrug-resistant (MDR) P. aeruginosa infections in the lungs. Phages, viruses that specifically target bacteria, offer strain-specific bactericidal activity, often bypassing mechanisms of antibiotic resistance. Recent studies demonstrate that phage monotherapy and phage-antibiotic combinations can effectively disrupt biofilms and enhance bacterial clearance, particularly when phage cocktails or targeted delivery systems are employed. Additionally, the review explores delivery routes for pulmonary infections and the formulation challenges that affect phage stability and bioavailability. Clinical cases and ongoing trials further underscore the feasibility and safety of phage therapy in real-world applications. However, hurdles such as phage immunogenicity, rapid clearance, and regulatory limitations must be addressed before widespread clinical implementation. Overall, phage therapy holds significant promise in overcoming the therapeutic stagnation posed by MDR P. aeruginosa, especially in chronic and nosocomial lung infections, and warrants continued research and clinical validation.
- Open Access
- 4 May 2024
- Published by Springer Nature in Cureus
- Vol. 16 (5) , e59645
A Brief Update on Inter-lab Quality Control (ILQC) Activities for COVID-19 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) by All India Institute of Medical Sciences (AIIMS) Nagpur, India
Inter-lab quality control (ILQC) is vital for ensuring reliable test results, especially when laboratories are using assays authorized for newly emerging pathogens. The Indian Council of Medical Research (ICMR), New Delhi, had developed a network of laboratories to assess the quality of real-time reverse transcription (RT) polymerase chain reaction (PCR) assays used in India to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a three-tier ILQC lab structure, All India Institute of Medical Sciences (AIIMS) Nagpur, an institute of national importance & a tertiary care hospital, was designated as a state quality control (QC) lab for the region of Maharashtra. ILQC activities were planned biannually. The ICMR had assigned 22 government and 19 private SARS-CoV-2 RT-PCR testing laboratories, under the Department of Microbiology, AIIMS Nagpur. AIIMS Nagpur had conducted four ILQC activities during 2020-2021. The finding of the ILQC assessment (cumulative includes all four ILQC) conducted by AIIMS Nagpur revealed that the results of 77% of laboratories were 100% concordant, the results of 14% of laboratories were 90%, and very few laboratories (i.e. 9%) showed <90% concordant.
- 4 May 2024
- Published by Springer Nature in Cureus
- Vol. 16 (5) , e59645
Open AccessA Brief Update on Inter-lab Quality Control (ILQC) Activities for COVID-19 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) by All India Institute of Medical Sciences (AIIMS) Nagpur, India
Inter-lab quality control (ILQC) is vital for ensuring reliable test results, especially when laboratories are using assays authorized for newly emerging pathogens. The Indian Council of Medical Research (ICMR), New Delhi, had developed a network of laboratories to assess the quality of real-time reverse transcription (RT) polymerase chain reaction (PCR) assays used in India to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a three-tier ILQC lab structure, All India Institute of Medical Sciences (AIIMS) Nagpur, an institute of national importance & a tertiary care hospital, was designated as a state quality control (QC) lab for the region of Maharashtra. ILQC activities were planned biannually. The ICMR had assigned 22 government and 19 private SARS-CoV-2 RT-PCR testing laboratories, under the Department of Microbiology, AIIMS Nagpur. AIIMS Nagpur had conducted four ILQC activities during 2020-2021. The finding of the ILQC assessment (cumulative includes all four ILQC) conducted by AIIMS Nagpur revealed that the results of 77% of laboratories were 100% concordant, the results of 14% of laboratories were 90%, and very few laboratories (i.e. 9%) showed <90% concordant.
- Open Access
- 27 January 2024
- Published by Springer Nature in Cureus
- Vol. 16 (1) , e53060
Neurological Manifestations of Scrub Typhus Infection in Pediatric Patient: A Case Report From Tertiary Care Hospital in Central India
Scrub typhus is a neglected tropical bacterial disease endemic in central India which can manifest as meningitis/meningoencephalitis in children. It is difficult to diagnose clinically, especially in the absence of eschar or rash. Scrub typhus is seldom considered the differential diagnosis of meningitis in the Indian subcontinent. Appropriate investigations can lead to early detection of infection and initiation of correct antibiotic treatment leading to better patient prognosis even when features of meningitis supervene. Here, we report a pediatric case of scrub typhus meningitis that could be saved due to timely investigations and initiation of appropriate antimicrobial agents.
- 27 January 2024
- Published by Springer Nature in Cureus
- Vol. 16 (1) , e53060
Open AccessNeurological Manifestations of Scrub Typhus Infection in Pediatric Patient: A Case Report From Tertiary Care Hospital in Central India
Scrub typhus is a neglected tropical bacterial disease endemic in central India which can manifest as meningitis/meningoencephalitis in children. It is difficult to diagnose clinically, especially in the absence of eschar or rash. Scrub typhus is seldom considered the differential diagnosis of meningitis in the Indian subcontinent. Appropriate investigations can lead to early detection of infection and initiation of correct antibiotic treatment leading to better patient prognosis even when features of meningitis supervene. Here, we report a pediatric case of scrub typhus meningitis that could be saved due to timely investigations and initiation of appropriate antimicrobial agents.
- Open Access
- 2 December 2023
- Published by Elsevier in Medical Mycology Case Reports
- Vol. 43, 100618
Chaetomium globosum: Spotting a scarce saprophyte in bacterial-fungal co-infection of the sinuses in a post-COVID-19 patient
- 2 December 2023
- Published by Elsevier in Medical Mycology Case Reports
- Vol. 43, 100618
Open AccessChaetomium globosum: Spotting a scarce saprophyte in bacterial-fungal co-infection of the sinuses in a post-COVID-19 patient
- Open Access
- 4 April 2022
- Published by Microbiology Society in Access Microbiology
- Vol. 4 (3) , 000330
Incidence of COVID-19 infection and its variation with demographic and clinical profile: lessons learned at a COVID-19 RT-PCR laboratory in Nagpur, India
Introduction. The coronavirus disease 2019 (COVID-19) pandemic emerged as a global health crisis in 2020. The first case in India was reported on 30 January 2020 and the disease spread throughout the country within months. Old persons, immunocompromised patients and persons with co-morbidities, especially of the respiratory system, have a more severe and often fatal outcome to the disease. In this study we have analysed the socio-demographic trend of the COVID-19 outbreak in Nagpur and adjoining districts. Methods. The study was conducted from April to December 2020. Nasopharyngeal and oropharyngeal swabs collected from suspected cases of COVID-19 were tested using reverse-transcription polymerase chain reaction (RT-PCR) at a diagnostic molecular laboratory at a tertiary care hospital in central India. Patient-related data on demographic profile and indication for testing were obtained from laboratory requisition forms. The results of the inconclusive repeat samples were also noted. The data were analysed using SPSS v24.0. Results. A total of 46 898 samples were received from April to December 2020, of which 41 410 were included in the study; 90.6 % of samples belonged to adults and 9.4 % belonged to children. The overall positivity rate in the samples was 19.3 %, although it varied over the period. The yield was significantly high in the elderly age group (25.5 %) and symptomatic patients (22.6 %). On repeat testing of patients whose first test was inconclusive, 17.1% were positive. There was a steady increase of both the number of tests and the rate of positivity in the initial period of the study, followed by a sharp decline. Conclusion. We can conclude that rigorous contact tracing and COVID-appropriate behaviour (wearing a mask, social distancing and hand hygiene) are required to break the chain of transmission. Elderly people are more susceptible to infection and should follow stringent precautions. It is also important to perform repeat testing of those individuals whose tests are inconclusive with fresh samples so that no positive cases are missed. Understanding of demographics is crucial for better management of this crisis and proper allocation of resources.
- 4 April 2022
- Published by Microbiology Society in Access Microbiology
- Vol. 4 (3) , 000330
Open AccessIncidence of COVID-19 infection and its variation with demographic and clinical profile: lessons learned at a COVID-19 RT-PCR laboratory in Nagpur, India
Introduction. The coronavirus disease 2019 (COVID-19) pandemic emerged as a global health crisis in 2020. The first case in India was reported on 30 January 2020 and the disease spread throughout the country within months. Old persons, immunocompromised patients and persons with co-morbidities, especially of the respiratory system, have a more severe and often fatal outcome to the disease. In this study we have analysed the socio-demographic trend of the COVID-19 outbreak in Nagpur and adjoining districts. Methods. The study was conducted from April to December 2020. Nasopharyngeal and oropharyngeal swabs collected from suspected cases of COVID-19 were tested using reverse-transcription polymerase chain reaction (RT-PCR) at a diagnostic molecular laboratory at a tertiary care hospital in central India. Patient-related data on demographic profile and indication for testing were obtained from laboratory requisition forms. The results of the inconclusive repeat samples were also noted. The data were analysed using SPSS v24.0. Results. A total of 46 898 samples were received from April to December 2020, of which 41 410 were included in the study; 90.6 % of samples belonged to adults and 9.4 % belonged to children. The overall positivity rate in the samples was 19.3 %, although it varied over the period. The yield was significantly high in the elderly age group (25.5 %) and symptomatic patients (22.6 %). On repeat testing of patients whose first test was inconclusive, 17.1% were positive. There was a steady increase of both the number of tests and the rate of positivity in the initial period of the study, followed by a sharp decline. Conclusion. We can conclude that rigorous contact tracing and COVID-appropriate behaviour (wearing a mask, social distancing and hand hygiene) are required to break the chain of transmission. Elderly people are more susceptible to infection and should follow stringent precautions. It is also important to perform repeat testing of those individuals whose tests are inconclusive with fresh samples so that no positive cases are missed. Understanding of demographics is crucial for better management of this crisis and proper allocation of resources.
- Open Access
- 24 January 2022
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e21541
Symptomatology and Relationship Between Symptoms and Duration Among COVID-19 Patients in a COVID-19 Care Hospital in Central India
The COVID-19 pandemic has affected the world population across the globe. India has the second largest number of cases and the third largest number of deaths due to COVID-19 in the world. There have been close to 4.4 lakh deaths due to COVID-19 in India alone. The second wave in India has led to devastating consequences, particularly among the young population. The initial clinical symptoms of COVID-19 are similar to all types of viral pneumonia, with varying degrees of severity. The cases’ clinical manifestations include fever, nonproductive cough, dyspnea, myalgia, and fatigue. This study was undertaken with the purpose of identifying the relationship between the symptoms and duration in COVID-19-affected patients. The common presenting symptoms were fever (44.5%), sore throat (38.7%), and cough (36.12%). Most of the cases presented with a combination of fever with cough (35%) and fever with sore throat (33%). The duration of symptoms varied from one to 17 days with a mean of 5.75 days. Despite vaccination being started, the risk of the imminent third wave in the country is existential. Mutations in the coronavirus pose a threat to the vulnerable population. It is important to identify the combination of symptoms most predictive of COVID-19 to help guide recommendations for self-isolation, testing, and preventing further spread of the disease. Further studies using these models can yield better results in surveillance and containing this infectious disease.
- 24 January 2022
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e21541
Open AccessSymptomatology and Relationship Between Symptoms and Duration Among COVID-19 Patients in a COVID-19 Care Hospital in Central India
The COVID-19 pandemic has affected the world population across the globe. India has the second largest number of cases and the third largest number of deaths due to COVID-19 in the world. There have been close to 4.4 lakh deaths due to COVID-19 in India alone. The second wave in India has led to devastating consequences, particularly among the young population. The initial clinical symptoms of COVID-19 are similar to all types of viral pneumonia, with varying degrees of severity. The cases’ clinical manifestations include fever, nonproductive cough, dyspnea, myalgia, and fatigue. This study was undertaken with the purpose of identifying the relationship between the symptoms and duration in COVID-19-affected patients. The common presenting symptoms were fever (44.5%), sore throat (38.7%), and cough (36.12%). Most of the cases presented with a combination of fever with cough (35%) and fever with sore throat (33%). The duration of symptoms varied from one to 17 days with a mean of 5.75 days. Despite vaccination being started, the risk of the imminent third wave in the country is existential. Mutations in the coronavirus pose a threat to the vulnerable population. It is important to identify the combination of symptoms most predictive of COVID-19 to help guide recommendations for self-isolation, testing, and preventing further spread of the disease. Further studies using these models can yield better results in surveillance and containing this infectious disease.
- Open Access
- 1 January 2020
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 151 (1) , 79-86
Exploration of population ecological factors related to the spatial heterogeneity of dengue fever cases diagnosed through a national network of laboratories in India, 2017
Background & objectives: Dengue virus (DENV) transmission is known to be influenced by the environmental conditions. During 2017, the Viral Research and Diagnostic Laboratories (VRDLs) tested 78,744 suspected dengue fever (DF) patients, of whom, 21,260 were laboratory confirmed. The objectives of the study were to evaluate the hypothesis that spatial heterogeneity existed for DF patients and to identify significant determinants of DENV transmission in various districts across the Indian States during 2017. Methods: Laboratory confirmed DF cases were analysed from 402 districts spread across the Indian States. The determinants for DF transmission included in the model were population density, proportion of population living in rural areas, proportion of forest cover area to the total geographical area, proportion of persons not able to read and write and who were aged greater than seven years; the climatic variables considered were minimum, maximum and average temperature, precipitation and cumulative rainfall. The spatial heterogeneity was assessed using spatial regression analysis. Results: DF cases showed strong spatial dependency, with Moran's I=4.44 (P<0.001). The robust measure for spatial lag (6.55; P=0.01) was found to be the best model fit for the data set. Minimum temperature and cumulative rainfall were significant predictors. Interpretation & conclusions: A significant increase in the number of dengue cases has occurred when the minimum temperature was 23.0-25.8°C and the cumulative rainfall 118.14-611.64 mm across the Indian districts. Further in-depth investigations incorporating more number of demographic, ecological and socio-economic factors would be needed for robust conclusions.
- 1 January 2020
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 151 (1) , 79-86
Open AccessExploration of population ecological factors related to the spatial heterogeneity of dengue fever cases diagnosed through a national network of laboratories in India, 2017
Background & objectives: Dengue virus (DENV) transmission is known to be influenced by the environmental conditions. During 2017, the Viral Research and Diagnostic Laboratories (VRDLs) tested 78,744 suspected dengue fever (DF) patients, of whom, 21,260 were laboratory confirmed. The objectives of the study were to evaluate the hypothesis that spatial heterogeneity existed for DF patients and to identify significant determinants of DENV transmission in various districts across the Indian States during 2017. Methods: Laboratory confirmed DF cases were analysed from 402 districts spread across the Indian States. The determinants for DF transmission included in the model were population density, proportion of population living in rural areas, proportion of forest cover area to the total geographical area, proportion of persons not able to read and write and who were aged greater than seven years; the climatic variables considered were minimum, maximum and average temperature, precipitation and cumulative rainfall. The spatial heterogeneity was assessed using spatial regression analysis. Results: DF cases showed strong spatial dependency, with Moran's I=4.44 (P<0.001). The robust measure for spatial lag (6.55; P=0.01) was found to be the best model fit for the data set. Minimum temperature and cumulative rainfall were significant predictors. Interpretation & conclusions: A significant increase in the number of dengue cases has occurred when the minimum temperature was 23.0-25.8°C and the cumulative rainfall 118.14-611.64 mm across the Indian districts. Further in-depth investigations incorporating more number of demographic, ecological and socio-economic factors would be needed for robust conclusions.
- Open Access
- 1 July 2019
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 84, S10-S14
Epidemiology of dengue fever in India, based on laboratory surveillance data, 2014–2017
- 1 July 2019
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 84, S10-S14
Open AccessEpidemiology of dengue fever in India, based on laboratory surveillance data, 2014–2017